| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 2 442-449, Copyright © 1996 by American Association of Immunologists
ARTICLES |
MA Bowen, RK Lee, G Miragliotta, SY Nam and ER Podack
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA.
Murine CD30 cDNA predicts a protein of 498 amino acids with homology to the TNF receptor family of proteins characterized by repeated cysteine- rich motifs in the extracellular domain. Murine CD30, although homologous to human CD30, has a 90 amino acid gap in an extracellular region that appears to be duplicated in human CD30. Murine CD30 cDNA was shown to be functional through the production of a soluble murine Ig fusion protein (CD30-Ig) that was active in binding to cells that expressed CD30 ligand. CD30-Ig also served as an immunogen for the production of hamster anti-mouse CD30 mAbs, which recognized both CD30 expressed by murine lymphocytes and CD30 expressed by cells transfected with murine CD30 cDNA. CD30 mRNA is highly expressed in the thymus and in activated spleen cells, but not in other tissues tested. In anti-CD3- activated spleen cells, CD30 ligand is expressed primarily by CD4+ T cells, with peak expression at days 1 and 2, whereas CD30 is expressed primarily by CD8+ T cells, with peak expression on days 4 and 5. Stimulation of CD30 by plate-bound anti-CD30 directly signaled for IL-5 but not IFN-gamma production by CD30+ CTL lines. These studies demonstrate that CD30 directs cytokine secretion and suggest that CD30 signaling may be pivotal in the pattern of cytokine production by T cells.
This article has been cited by other articles:
|
|
 |
|
  J. N. H. Stern, D. B. Keskin, H. Zhang, H. Lv, Z. Kato, and J. L. Strominger Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice PNAS, April 1, 2008; 105(13): 5172 - 5176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease Blood, March 1, 2007; 109(5): 2225 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nishimura, T. Yajima, H. Muta, E. R. Podack, K. Tani, and Y. Yoshikai A Novel Role of CD30/CD30 Ligand Signaling in the Generation of Long-Lived Memory CD8+ T Cells J. Immunol., October 1, 2005; 175(7): 4627 - 4634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Dai, I. W. Nasr, M. Reel, S. Deng, L. Diggs, C. P. Larsen, D. M. Rothstein, and F. G. Lakkis Impaired Recall of CD8 Memory T Cells in Immunologically Privileged Tissue J. Immunol., February 1, 2005; 174(3): 1165 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Blazar, R. B. Levy, T. W. Mak, A. Panoskaltsis-Mortari, H. Muta, M. Jones, M. Roskos, J. S. Serody, H. Yagita, E. R. Podack, et al. CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease J. Immunol., September 1, 2004; 173(5): 2933 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Toennies, J. M. Green, and R. H. Arch Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms J. Leukoc. Biol., February 1, 2004; 75(2): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harlin, E. Podack, M. Boothby, and M.-L. Alegre TCR-Independent CD30 Signaling Selectively Induces IL-13 Production Via a TNF Receptor-Associated Factor/p38 Mitogen-Activated Protein Kinase-Dependent Mechanism J. Immunol., September 1, 2002; 169(5): 2451 - 2459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Panus, C. A. Smith, C. A. Ray, T. D. Smith, D. D. Patel, and D. J. Pickup Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue PNAS, June 11, 2002; 99(12): 8348 - 8353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yamada, A. D. Salama, and M. H. Sayegh The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575. [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Y. Wang, A. Thern, A. Denzel, J. Kitson, S. N. Farrow, and M. J. Owen DR3 Regulates Negative Selection during Thymocyte Development Mol. Cell. Biol., May 15, 2001; 21(10): 3451 - 3461. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. DeYoung, O. Duramad, and A. Winoto The TNF Receptor Family Member CD30 Is Not Essential for Negative Selection J. Immunol., December 1, 2000; 165(11): 6170 - 6173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Muta, L. H. Boise, L. Fang, and E. R. Podack CD30 Signals Integrate Expression of Cytotoxic Effector Molecules, Lymphocyte Trafficking Signals, and Signals for Proliferation and Apoptosis J. Immunol., November 1, 2000; 165(9): 5105 - 5111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Croager, A. M. Gout, and L. J. Abraham Involvement of Sp1 and Microsatellite Repressor Sequences in the Transcriptional Control of the Human CD30 Gene Am. J. Pathol., May 1, 2000; 156(5): 1723 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamazaki, T. Nguyen, and E. R. Podack Cutting Edge: Tumor Secreted Heat Shock-Fusion Protein Elicits CD8 Cells for Rejection J. Immunol., November 15, 1999; 163(10): 5178 - 5182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sepulveda, A. Cerwenka, T. Morgan, and R. W. Dutton CD28, IL-2-Independent Costimulatory Pathways for CD8 T Lymphocyte Activation J. Immunol., August 1, 1999; 163(3): 1133 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kishimoto and J. Sprent Several Different Cell Surface Molecules Control Negative Selection of Medullary Thymocytes J. Exp. Med., July 5, 1999; 190(1): 65 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chiarle, A. Podda, G. Prolla, E. R. Podack, G. J. Thorbecke, and G. Inghirami CD30 Overexpression Enhances Negative Selection in the Thymus and Mediates Programmed Cell Death Via a Bcl-2-Sensitive Pathway J. Immunol., July 1, 1999; 163(1): 194 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Hanekom, G. D. Hussey, E. J. Hughes, S. Potgieter, R. Yogev, and I. J. Check Plasma-Soluble CD30 in Childhood Tuberculosis: Effects of Disease Severity, Nutritional Status, and Vitamin A Therapy Clin. Vaccine Immunol., March 1, 1999; 6(2): 204 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Harrop, M. Reddy, K. Dede, M. Brigham-Burke, S. Lyn, K. B. Tan, C. Silverman, C. Eichman, R. DiPrinzio, J. Spampanato, et al. Antibodies to TR2 (Herpesvirus Entry Mediator), a New Member of the TNF Receptor Superfamily, Block T Cell Proliferation, Expression of Activation Markers, and Production of Cytokines J. Immunol., August 15, 1998; 161(4): 1786 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Romagnani, F. Annunziato, R. Manetti, C. Mavilia, L. Lasagni, C. Manuelli, G. B. Vannelli, V. Vanini, E. Maggi, C. Pupilli, et al. High CD30 Ligand Expression by Epithelial Cells and Hassal's Corpuscles in the Medulla of Human Thymus Blood, May 1, 1998; 91(9): 3323 - 3332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Gilfillan, P. J. Noel, E. R. Podack, S. L. Reiner, and C. B. Thompson Expression of the Costimulatory Receptor CD30 Is Regulated by Both CD28 and Cytokines J. Immunol., March 1, 1998; 160(5): 2180 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Punt, W. Havran, R. Abe, A. Sarin, and A. Singer T Cell Receptor (TCR)-induced Death of Immature CD4+CD8+ Thymocytes by Two Distinct Mechanisms Differing in Their Requirement for CD28 Costimulation: Implications for Negative Selection in the Thymus J. Exp. Med., December 1, 1997; 186(11): 1911 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Denzer, R. Brandenberger, M. Gesemann, M. Chiquet, and M. A. Ruegg Agrin Binds to the Nerve-Muscle Basal Lamina via Laminin J. Cell Biol., May 5, 1997; 137(3): 671 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Gattei, M. Degan, A. Gloghini, A. De Iuliis, S. Improta, F. M. Rossi, D. Aldinucci, V. Perin, D. Serraino, R. Babare, et al. CD30 Ligand Is Frequently Expressed in Human Hematopoietic Malignancies of Myeloid and Lymphoid Origin Blood, March 15, 1997; 89(6): 2048 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aizawa, H. Nakano, T. Ishida, R. Horie, M. Nagai, K. Ito, H. Yagita, K. Okumura, J. Inoue, and T. Watanabe Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5and TRAF2 Are Involved in CD30-mediated NFkappa B Activation J. Biol. Chem., January 24, 1997; 272(4): 2042 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ansieau, I. Scheffrahn, G. Mosialos, H. Brand, J. Duyster, K. Kaye, J. Harada, B. Dougall, G. Hubinger, E. Kieff, et al. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation PNAS, November 26, 1996; 93(24): 14053 - 14058. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
